Shapira I, Isakov A, Yakirevich V, Topilsky M
Department of Medicine H, Tel Aviv E. Sourasky Medical Center, Tel Aviv University, Israel.
Chest. 1995 Dec;108(6):1546-50. doi: 10.1378/chest.108.6.1546.
The objective of the present study was to evaluate medium- and long-term results of coronary artery bypass grafting (CABG) in patients with severe left ventricular dysfunction (LVD).
Prospective evaluation (clinical follow-up and equilibrium radionuclide angiography scan) of all the patients with severe LVD who underwent CABG from November 1986 to November 1991 at the Tel Aviv Medical Center and were referred to the Post Cardiac Surgery Follow-up Clinic at this institution.
Seventy-four consecutive patients (65 men, 9 women, aged 43 to 82 years; mean age, 68.2 years) with left ventricular ejection fraction (LVEF) of 30% or less who underwent isolated CABG (without automatic implantable cardioverter-defibrillator implantation, aneurysmectomy, valve replacement, or other open heart procedures) during a 5-year period and were discharged from hospitalization were prospectively evaluated. Preoperatively, 62% of patients had angina, 65% had congestive heart failure (CHF), and the LVEF ranged from 10 to 30%. The mean number of grafts was 2.98 per patient; the internal mammary artery (IMA) was used in 54 patients. The patients were followed up 4 to 96 months (mean, 64.9 months) post-surgery for survival, clinical status, and left ventricular function.
Survival was 96%, 93.2%, 91.9%, 87.8%, 86.5%, 83.8%, and 83.8%, at 1, 2, 3, 4, 5, 6, and 7 years, respectively. Postoperatively, mean angina class improved from 2.9 to 1.4 (p < 0.0001) and mean CHF class improved from 2.7 to 1.8 (p < 0.0001). Mean LVEF improved from 23.5% preoperatively to 35.7% postoperatively (p < 0.0001).
The following occur in patients with coronary artery disease and severe LVD undergoing CABG: (1) good medium- and long-term survival is attained; (2) angina class improves; (3) CHF class improves; (4) LVEF objectively improves; and (5). IMA can be used safely as a conduit.
本研究的目的是评估严重左心室功能不全(LVD)患者冠状动脉旁路移植术(CABG)的中长期结果。
对1986年11月至1991年11月在特拉维夫医疗中心接受CABG且被转诊至该机构心脏外科术后随访门诊的所有严重LVD患者进行前瞻性评估(临床随访和平衡放射性核素血管造影扫描)。
连续74例患者(65例男性,9例女性,年龄43至82岁;平均年龄68.2岁),左心室射血分数(LVEF)为30%或更低,在5年期间接受单纯CABG(未植入自动植入式心脏复律除颤器、未行动脉瘤切除术、瓣膜置换术或其他心脏直视手术)并出院,接受前瞻性评估。术前,62%的患者有心绞痛,65%的患者有充血性心力衰竭(CHF),LVEF范围为10%至30%。每位患者平均移植血管数为2.98条;54例患者使用了乳内动脉(IMA)。对患者术后4至96个月(平均64.9个月)的生存情况、临床状态和左心室功能进行随访。
1年、2年、3年、4年、5年、6年和7年的生存率分别为96%、93.2%、91.9%、87.8%、86.5%、83.8%和83.8%。术后,平均心绞痛分级从2.9改善至1.4(p < 0.0001),平均CHF分级从2.7改善至1.8(p < 0.0001)。平均LVEF从术前的23.5%改善至术后的35.7%(p < 0.0001)。
患有冠状动脉疾病和严重LVD且接受CABG的患者会出现以下情况:(1)获得良好的中长期生存;(2)心绞痛分级改善;(3)CHF分级改善;(4)LVEF客观改善;(5)IMA可安全用作血管 conduit。 (注:原文中“conduit”直译为“管道”,结合语境这里可理解为“血管移植物”之类意思,译文此处表述保留英文以便准确传达原文含义)